Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HCW Biologics (HCWB) Other Non-Current Assets (2020 - 2025)

Historic Other Non-Current Assets for HCW Biologics (HCWB) over the last 6 years, with Q3 2025 value amounting to $28476.0.

  • HCW Biologics' Other Non-Current Assets changed 0.0% to $28476.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $28476.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $28476.0 for FY2024, which is 4963.39% down from last year.
  • Latest data reveals that HCW Biologics reported Other Non-Current Assets of $28476.0 as of Q3 2025, which was down 0.0% from $28477.0 recorded in Q2 2025.
  • HCW Biologics' 5-year Other Non-Current Assets high stood at $686414.0 for Q1 2022, and its period low was $28476.0 during Q1 2024.
  • Its 5-year average for Other Non-Current Assets is $203362.9, with a median of $97082.0 in 2023.
  • Per our database at Business Quant, HCW Biologics' Other Non-Current Assets surged by 104864.2% in 2021 and then crashed by 8875.11% in 2024.
  • Over the past 5 years, HCW Biologics' Other Non-Current Assets (Quarter) stood at $393318.0 in 2021, then dropped by 15.11% to $333875.0 in 2022, then tumbled by 83.07% to $56538.0 in 2023, then plummeted by 49.63% to $28476.0 in 2024, then changed by 0.0% to $28476.0 in 2025.
  • Its last three reported values are $28476.0 in Q3 2025, $28477.0 for Q2 2025, and $28476.0 during Q1 2025.